Effects and mechanisms of hemopoiesis-stimulating activity of immobilized oligonucleotides under conditions of cytostatic myelosuppression

Bulletin of Experimental Biology and Medicine

Volumn 152, Issue 4, 2012, Pages 451-455

  Dygai, A M ^a   Goldberg, V E ^a   Artamonov, A V ^b   Bekarev, A A ^b   Vereschagin, E I ^b   Madonov, P G ^b   Skurikhin, E G ^a   Pershina, O V ^a   Andreeva, T V ^a   Khmelevskaya, E S ^a   Ermakova, N N ^a  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^b Scientific Future Management   (Russian Federation)

Author keywords

Cytostatics; Hemopoiesis; Hemopoietic precursors; Immobilized oligonucleotides; Individual sensitivity

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DNA FRAGMENT; FLUOROURACIL; IMMOBILIZED OLIGONUCLEOTIDE; MACROGOL; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW SUPPRESSION; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; ERYTHROPOIESIS; GRANULOCYTE; GRANULOPOIESIS; HEMOPOIESIS STIMULATING ACTIVITY; LEUKOCYTE COUNT; MONOCYTE MACROPHAGE PRECURSOR CELL; NONHUMAN; THROMBOCYTE COUNT;

EID: 85027955369     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-012-1551-9     Document Type: Article

References (15)

1. M. B. Belogurova, Praktich. Onkol., 4, No. 3, 183-190 (2003).
2. E. D. Goldberg, A. M. Dygai, and V. P. Shakhov, Tissue Culture Methods in Hematology [in Russian], Tomsk (1992).
3. E. D. Goldberg, A. M. Dygai, V. V. Zhdanov, et al., Drug Regulation of Blood System in Experimental Neurotic Exposure [in Russian], Tomsk (2007).
4. L. K. Pashuk, G. N. Apryshko, and E. M. Treshchalina, Khim. Farm. Zh., No. 6, 61-64 (1995).
5. G. E. Pozmogova and D. G. Knorre, Vopr. Med. Khim., No. 6, 878-882 (1999).
6. Manual of Chemotherapy of Tumorous Diseases, Ed. N. I. Perevodchikova [in Russian], Moscow (2005).
7. G. G. Rusinova, Biokhimiya, 36, No. 5, 889-897 (1971).
8. R. D. Seifulla, A. B. Timofeev, Z. G. Ordzhonikidze, et al., Eksp. Klin. Farmakol., 71, No. 1, 60-69 (2008).
9. E. G. Skurikhin, O. V. Pershina, L. A. Stavrova, et al., Byull. Eksp. Biol. Med., 140, No. 8, 136-141 (2005).
10. Drug Encyclopedia, Ed. G. L. Vyshkovskii [in Russian], No. 15, Moscow (2006), P. 1488.
11. J. A. Glaspy, Oncology, 17, No. 11, 1593-1603 (2003).
12. A. Jäschke, J. P. Fürste, E. Nordhoff, et al., Nucleic Acids Res., 22, 4810-4817 (1994).
13. D. Patinkin, A. Hidmi, L. Weiss, et al., Oligonucleotides, 13, No. 4, 207-213 (2004).
14. D. M. Piedmonte and M. J. Treuheit, Adv. Drug Deliv. Rev., 60, No. 1, 50-58 (2008).
15. T. Vial and J. Descotes, Drug Saf., 13, No. 6, 371-406 (1995).